Reneo Pharmaceuticals, Inc. (RPHM)
NASDAQ: RPHM · IEX Real-Time Price · USD
1.670
+0.020 (1.21%)
Mar 28, 2024, 1:15 PM EDT - Market open

Reneo Pharmaceuticals Stock Forecast

RPHM's stock price has decreased by -69.19% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts with 12-month price forecasts for RPHM stock have an average target of 11.46, with a low estimate of 1.00 and a high estimate of 30. The average target predicts an increase of 586.23% from the current stock price of 1.67.

Analyst Consensus: Buy
Target Low Average Median High
Price $1.00 $11.46 $1.80 $30
Change -40.12% +586.23% +7.78% +1696.4%
* Price targets were last updated on Dec 15, 2023.

Analyst Ratings

The average analyst rating for RPHM stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 332222
Buy 011111
Hold 003333
Sell 000000
Strong Sell 000000
Total 346666

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
$30$1.5
Hold Downgrades $30$1.5 -10.18% Dec 15, 2023
Jefferies
Jefferies
Hold
Downgrades
$17$1.8
Hold Downgrades $17$1.8 +7.78% Dec 15, 2023
Leerink Partners
Leerink Partners
Hold
Downgrades
$1
Hold Downgrades $1 -40.12% Dec 15, 2023
William Blair
William Blair
Buy
Initiates
n/a
Buy Initiates n/a n/a Nov 15, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +1,696.41% Nov 14, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.46
from -2.12
EPS Next Year
-0.85
from -2.46
Year 2019202020212022202320242025202620272028
Revenue
-------120.64M212.65M334.83M
Revenue Growth
--------76.27%57.46%
EPS
-6.38-9.60-2.19-2.12-2.46-0.85-0.701.474.275.83
EPS Growth
--------190.97%36.52%
No. Analysts ----884333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202320242025202620272028
High n/a n/a n/a 205.3M 354.9M 529.8M
Avg n/a n/a n/a 120.6M 212.7M 334.8M
Low n/a n/a n/a 40.2M 77.4M 149.0M

Revenue Growth

Revenue Growth 202320242025202620272028
High - - - -
194.1%
149.1%
Avg - - - -
76.3%
57.5%
Low - - - -
-35.8%
-30.0%

EPS Forecast

EPS 202320242025202620272028
High -2.36 -0.66 -0.59 1.51 4.40 6.01
Avg -2.46 -0.85 -0.70 1.47 4.27 5.83
Low -2.60 -1.15 -0.79 1.41 4.11 5.61

EPS Growth

EPS Growth 202320242025202620272028
High - - - -
199.5%
40.5%
Avg - - - -
191.0%
36.5%
Low - - - -
179.6%
31.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.